Complete your studies efficiently and effectively with the flexibility of Affymetrix GeneChip products and services. We offer a range of options for using our technologies. You can use the GeneChip system in your own lab, rely on Affymetrix to coordinate your study, or work directly with a company in our network of providers.
http://investor.affymetrix.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Tuesday
LOAD TIME
PAGES IN
THIS WEBSITE
3
SSL
EXTERNAL LINKS
51
SITE IP
184.51.0.218
LOAD TIME
0 sec
SCORE
6.2
Affymetrix - About Affymetrix - Investors - Investors | investor.affymetrix.com Reviews
https://investor.affymetrix.com
Complete your studies efficiently and effectively with the flexibility of Affymetrix GeneChip products and services. We offer a range of options for using our technologies. You can use the GeneChip system in your own lab, rely on Affymetrix to coordinate your study, or work directly with a company in our network of providers.
investor.affymetrix.com
Process Calendar
http://investor.affymetrix.com/ProcessCalendarRequest.asp?eventId=5197476&OverridePage=irol-EventDetails&checkJS=false
Affymetrix - About Affymetrix - Investors - Press Release
http://investor.affymetrix.com/phoenix.zhtml?c=116408&p=irol-newsArticle&ID=2047916
USB Molecular Biology Reagents. Powered by Affymetrix Partners. Expression Array Comparison Tool. Mar 31 16 4:00 pm ET. The stock price performance shown on the quote above is not necessarily indicative of future price performance. Affymetrix Acquires Assets of Eureka Genomics Corporation to Provide High Throughput and Economical Crop and Animal Genotyping. SANTA CLARA, Calif. BUSINESS WIRE)- May 14, 2015-. NASDAQ:AFFX) announced today that it has acquired substantially all the assets of. Has achieved gr...
Affymetrix - About Affymetrix - Investors - Investors
http://investor.affymetrix.com/phoenix.zhtml?c=116408&p=irol-IRHome&navMode=34024&aId=aboutNav
USB Molecular Biology Reagents. Powered by Affymetrix Partners. Expression Array Comparison Tool. Mar 31 16 4:00 pm ET. The stock price performance shown on the quote above is not necessarily indicative of future price performance. VP Investor Relations and Treasury. Affymetrix Provides Notice to Holders of its Convertible Notes. Click here for PDF. Santa Clara, Calif. March 31, 2016. Thermo Fisher Scientific Completes Acquisition of Affymetrix Following Approval of Transaction by Affymetrix Stockholders.
TOTAL PAGES IN THIS WEBSITE
3
ADT Investor Information |
ADT Announces Appointment of Jeff Likosar as Chief Financial Officer. Read the Press Release. THE ADT CORPORATION FINANCIALS. View financial information about The ADT Corporation and Prime Security Services Borrower LLC. Login and View Documents. Access to our confidential financials and investor presentations requires a secure login. Submit a Financial Information Request. If you do not have access to view our documents, click here to access our registration request. Designed by Elegant Themes.
Aeolus Pharmaceuticals - Investor Relations
About Cancer Radiation Therapy. Effect on different types of cancer. History of radiation therapy. About Acute Radiation Syndrome. Overview of Acute Radiation Syndrome. The Project BioShield Act. Draft BARDA Strategic Plan. FDA Guidance For Industry. You are here: Home. We are developing a platform of a new class of broad-spectrum catalytic antioxidant. Compounds based on technology discovered at Duke University. Jun 8, 2017. May 15, 2017. View all releases ».
Reports, Filings & Statements - Investor Info | Aetna
Click Menu to close. Click to open Menu. Reports, Filings and Statements. Reports, Filings and Statements. View, print or download financial reports including earnings releases, financial supplements, guidance summaries, Form 10Qs and 10Ks. Snapshot of Aetna’s current financial metrics, ratios and trading statistics. Search Aetna’s SEC filings library and download the documents, including Section 16 filings, in pdf or html format. Reports, Filings, and Statements. You are now leaving the Aetna website.
AFFINIA - SEC Filings
SEC Filing Keyword Search. View SEC Groupings descriptions. View Section 16 Filings (3,4,5). Report of unscheduled material events or corporate event. Report of unscheduled material events or corporate event. Report of unscheduled material events or corporate event. Quarterly report which provides a continuing view of a company's financial position. Report of unscheduled material events or corporate event. Annual report which provides a comprehensive overview of the company for the past year.
Affymetrix - About Affymetrix - Investors - Investors
Powered by Affymetrix Partners. Aug 07 15 4:00 pm ET. The stock price performance shown on the quote above is not necessarily indicative of future price performance. Q2 2015 Affymetrix Earnings Conference Call. 160;at 5:00 pm ET. Q2 2015 Affymetrix Earnings Conference Call. Wednesday, July 29, 2015 . 5:00 pm ET . Click here for webcast. Click here to add this event to your calendar. VP Investor Relations and Treasury. Affymetrix Reports Second Quarter 2015 Operating Results. SANTA CLARA, Calif.- (BU...
Alliance Fiber Optic Products, Inc. - Investor Relations
Skip to Main Content. Annual Report and Proxy. Proxy Statement - Annual Meeting. At Alliance Fiber Optic Products, Inc. (NASDAQ: AFOP). View all ». Jul 22, 2015. AFOP Reports Record Quarterly Sales in Q2 2015; Guidance for Year-Over-Year Increases of 33% in Q3 2015. Jul 6, 2015. AFOP Announces the Second Quarter Preliminary Results With Record Revenues, and the Second Quarter Conference Call Invitation.
Agenus Bio Investor Center |
Activities What we do. Financial How we build value. News Our latest updates. Contact How to get in touch. July 24, 2015. GSK’s Malaria Vaccine Containing Agenus’ QS-21 Stimulon Receives Positive Opinion from European Regulators for Prevention of Malaria in Young Children in Sub-Saharan Africa. July 23, 2015. Agenus Reports Second Quarter 2015 Financial Results. July 20, 2015. Agenus Acquires Novel Antibodies to Immuno-oncology Target CEACAM1. July 16, 2015. Agenus to Report Second Quarter 2015 Financial...
Agilent | Investor Overview
Q3 2015 Agilent Technologies Inc. Earnings Conference Call. August 17, 2015. 160;at 1:30 pm PT. AGILENT TECHNOLOGIES COMPLETES SPIN-OFF OF KEYSIGHT TECHNOLOGIES. On Sept. 19, 2013, Agilent announced plans to separate into two publicly traded companies through a tax-free spinoff of its electronic measurement business, now called Keysight Technologies. All of the outstanding shares in Keysight were distributed to Agilent shareholders on November 1, 2014. Keysight Investor Relations Website. August 17, 2015.
Overview- Agios
Annual Report and Proxy. Agios is a biopharmaceutical company passionately committed to applying our scientific leadership in the field of cellular metabolism to transform the lives of patients with cancer and rare genetic disorders of metabolism. 160; 2.23. Aug 06, 2015. Agios Reports Second Quarter 2015 Financial Results and Provides Updates on Clinical Development Progress. Aug 05, 2015. Agios to Present at Canaccord Genuity 35th Annual Growth Conference Wednesday, August 12, 2015. Jul 30, 2015.
A. H. Belo Corporation - Overview
About A. H. Belo. A H Belo Companies. Advertising with A. H. Belo. Second Quarter 2015 A. H. Belo Corporation Financial Results Conference Call - Transcript. The Dallas Morning News. Texas' leading newspaper and winner of nine Pulitzer Prizes; the. And Wanderful Media, LLC, owner of. A H Belo Corporation Announces Second Quarter 2015 Financial Results from Continuing Operations. A H Belo Corporation Announces Schedule for Second Quarter 2015 Financial Results Release and Conference Call. Â Â Past Events.
